I agree that this site is using cookies. You can find further informations here.
X
Dillon, Stacey
149  results:
Search for persons X
?
1

S276: POVETACICEPT (ALPN-303), A POTENT DUAL BAFF/APRIL ANT..:

Dillon, Stacey ; Davies, Rupert ; Lickliter, Jason...
HemaSphere.  7 (2023)  S3 - p. e3301055 , 2023
Link: https://doi.org/10.1097/..
 
?
2

P156 ALPN-101, A FIRST-IN-CLASS DUAL ICOS/CD28 ANTAGONIST, ..:

Swiderek, Kristine ; Dillon, Stacey ; Moore, John...
Inflammatory Bowel Diseases.  26 (2020)  Supplement_1 - p. S4-S4 , 2020
Link: https://doi.org/10.1093/..
 
?
3

P156 ALPN-101, A FIRST-IN-CLASS DUAL ICOS/CD28 ANTAGONIST, ..:

Swiderek, Kristine ; Dillon, Stacey ; Moore, John...
Gastroenterology.  158 (2020)  3 - p. S7 , 2020
Link: https://doi.org/10.1053/..
 
?
4

Association of Lifestyle and Relationship Factors with Sexu..:

Hess, Rachel ; Conroy, Molly B. ; Ness, Roberta...
The Journal of Sexual Medicine.  6 (2009)  5 - p. 1358-1368 , 2009
Link: https://doi.org/10.1111/..
 
?
5

Nonclinical Safety, Pharmacokinetics, and Pharmacodynamics ..:

Carbonatto, Michela ; Yu, Ping ; Bertolino, Mauro...
Toxicological Sciences.  105 (2008)  1 - p. 200-210 , 2008
Link: https://doi.org/10.1093/..
 
?
6

42273 Phase 1 Study in Healthy Adults of the Safety, Tolera..:

Dillon, Stacey R. ; Davies, Rupert H. ; Lickliter, Jason D....
Journal of the American Academy of Dermatology.  89 (2023)  3 - p. AB74 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Non‐Redundant Roles of T Cell Costimulation Pathways in Inf..:

Dillon, Stacey R. ; Evans, Lawrence S. ; Lewis, Katherine E....
Arthritis & Rheumatology.  75 (2023)  8 - p. 1344-1356 , 2023
Link: https://doi.org/10.1002/..
 
?
8

Systemic Administration of Acazicolcept, a Dual CD28 and In..:

Wilson, Leslie ; Lewis, Katherine E. ; Evans, Lawrence S...
Translational Vision Science & Technology.  12 (2023)  3 - p. 27 , 2023
Link: https://doi.org/10.1167/..
 
?
9

Povetacicept, an Enhanced Dual APRIL/BAFF Antagonist That M..:

Evans, Lawrence S. ; Lewis, Katherine E. ; DeMonte, Daniel...
Arthritis & Rheumatology.  75 (2023)  7 - p. 1187-1202 , 2023
Link: https://doi.org/10.1002/..
 
?
10

The engineered CD80 variant fusion therapeutic davoceticept..:

Maurer, Mark F. ; Lewis, Katherine E. ; Kuijper, Joseph L....
Nature Communications.  13 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
11

Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demon..:

Orvain, Cindy ; Cauvet, Anne ; Prudent, Alexis...
Arthritis Research & Therapy.  24 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
12

Mo1093 ALPN-101, A FIRST-IN-CLASS DUAL ICOS/CD28 ANTAGONIST..:

Dillon, Stacey R. ; Evans, Lawrence S. ; Bort, Susan...
Gastroenterology.  158 (2020)  6 - p. S-786 , 2020
Link: https://doi.org/10.1016/..
 
?
13

IL‐31 transgenic mice show reduced allergen‐induced lung in..:

Neuper, Theresa ; Neureiter, Daniel ; Sarajlic, Muamera...
European Journal of Immunology.  51 (2020)  1 - p. 191-196 , 2020
Link: https://doi.org/10.1002/..
 
?
14

Novel Immunomodulatory Proteins Generated via Directed Evol..:

Levin, Steven D. ; Evans, Lawrence S. ; Bort, Susan...
Frontiers in Immunology.  10 (2020)  - p. , 2020
Link: https://doi.org/10.3389/..
 
?
15

Alpn-101, a Dual ICOS/CD28 Antagonist, Demonstrates Potent ..:

Dillon, Stacey R. ; Yang, Jing ; Lewis, Katherine E....
Biology of Blood and Marrow Transplantation.  25 (2019)  3 - p. S290-S291 , 2019
Link: https://doi.org/10.1016/..
 
1-15